Palvella Therapeutics, Inc. Other Non-Current Liabilities
Palvella Therapeutics, Inc. (PVLA) had Other Non-Current Liabilities of $0 as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2023-08-10
- 2023-06-30: Other Liabilities, Noncurrent $0.00.
- 2022-12-31: Other Liabilities, Noncurrent $0.00.
- 2021-12-31: Other Liabilities, Noncurrent $0.00.
- 2021-09-30: Other Liabilities, Noncurrent $0.00.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 | |
| 2022-12-31 | $0.00 10-Q · filed 2023-08-10 | |
| 2021-12-31 | $0.00 10-K · filed 2022-03-02 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $6.00K 10-K · filed 2022-03-02 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 | |
| 2019-09-30 | $12.08M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $12.32M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $27.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $27.00K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $32.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $37.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $37.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $37.00K 10-K · filed 2019-03-18 | |
| 2017-09-30 | $43.46K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $42.86K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $42.09K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $47.00K 10-K · filed 2018-03-15 | $46.67K 10-K · filed 2017-03-30 |
| 2016-09-30 | $44.56K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $42.06K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $39.74K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $23.85K 10-K · filed 2017-03-30 | |
| 2015-06-30 | $307.85K 10-Q · filed 2015-08-13 | |
| 2014-12-31 | $333.99K 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |